Blog

Welcome to the Toronto Chapter!

Hello World! My name is Matan and I am the Toronto Chapter Coordinator for the PKD Foundation of Canada. I was diagnosed with PKD 13 years ago, after progressively worse flank pain led me to seek medical attention. Heading up our Toronto Chapter allows me to redirect my energy into helping others affected by PKD. It helps me forget about my challenges and focus on leaving my community a bit better, day by day.

As a PKD patient I feel blessed because some of the world’s top scientists are fighting for our cause. With many studies currently underway, I believe the future of PKD is very promising for patients. Our Toronto Chapter understands the importance of continued research, advocacy and education on PKD and strives to grow our community with the help of dedicated volunteers.

PKD patients can reach out to me at any time and for any reason at torontochapter@endpkd.ca. Our Toronto Chapter is looking forward to implementing even more educational and social events this year. We aim to consistently improve the help we deliver to our community and the value we deliver to our PKD patients. Thank you for your support!

National Kidney Month & World Kidney Day!

Kidney Month is recognized in March across Canada and the United States. We spend this time raising awareness of the importance of our kidneys to our overall health, and to reduce the frequency and impact kidney disease and its associated health problems have on an international level. We encourage you all to get out there and share your PKD journey with as many people as possible!

Happy Holidays

Season's greetings to you and yours from the PKD Foundation of Canada!

The New England Journal of Medicine Publishes Phase 3 Results for Tolvaptan in Patients with ADPKD

We are pleased to share some encouraging news regarding the treatment landscape for those living with ADPKD. Today, Otsuka announced results from their Phase 3 REPRISE trial of tolvaptan in patients with autosomal dominant polycystic kidney disease (ADPKD). This data was presented at the American Society of Nephrology (ASN) Conference in New Orleans and published online in the New England Journal of Medicine.

Large Tolvaptan Trial Results Show Positive Future for ADPKD Patients

We are glad to share some great news for the Canadian PKD community, as tolvaptan receives positive results from an additional one year international trial. The trial outcome was positive for tolvaptan in the treatment of ADPKD. Also of note, the trial had participation from Canadian patients and nephrologists.